QXO, Inc. 8-K

What Happened

• QXO entered into a definitive Agreement and Plan of Merger to acquire TopBuild via a two-step merger structure (Titanium Merger and Forward Merger). QXO filed a Form S-4 (File No. 333-295973) that was declared effective by the SEC on May 29, 2026, and the joint proxy/prospectus was mailed the same day. Special meetings of QXO and TopBuild stockholders are scheduled for June 29, 2026 to vote on the transactions.
• On June 8, 2026 a purported QXO stockholder filed Thompson v. QXO, Inc., Case No. 2026-0757 in the Delaware Court of Chancery, alleging the QXO board failed to disclose material information needed for an informed vote; the complaint seeks to enjoin the mergers, certify a class and recover fees/costs. QXO and TopBuild also received multiple demand letters from stockholders alleging omissions in the joint proxy.
• QXO and TopBuild deny the allegations but voluntarily supplemented the joint proxy statement/prospectus (via this 8-K) to add disclosures—most notably additional detail about Morgan Stanley’s fees and relationships—solely to avoid potential delays or distractions. The QXO Board continues to unanimously recommend that QXO stockholders vote “FOR” the listed proposals.

Key Details

• Registration statement: Form S-4, File No. 333-295973, declared effective May 29, 2026; joint proxy mailed May 29, 2026; stockholder meetings set for June 29, 2026.
• Litigation: Complaint filed June 8, 2026 in Delaware Court of Chancery (Thompson v. QXO, Inc., Case No. 2026-0757); seeks injunction, class certification, attorneys’ fees.
• Financial advisor disclosure added: Morgan Stanley and affiliates received aggregate fees between $85 million and $110 million from QXO in the past two years and are expected to receive an additional estimated $19–$21 million (plus expenses) related to financing, bridge facilities, term loan, notes and tender offers; Morgan Stanley received no advisory/financing fees from TopBuild in the prior two years and is also a lender under a QXO credit facility.

Why It Matters

• The lawsuit and demand letters raise the risk of delay or challenge to the merger vote; courts could order supplemental disclosures or temporarily enjoin the transactions, affecting the timing of the deal.
• The supplemental disclosure about Morgan Stanley’s fees and relationships addresses potential advisor conflict-of-interest concerns that investors often consider when evaluating fairness of merger terms.
• Investors should review the amended joint proxy/prospectus and consider the pending litigation and recent disclosures before voting; copies of filings are available on the SEC website and QXO/TopBuild investor sites.